Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-034631
Filing Date
2021-05-20
Accepted
2021-05-20 19:28:25
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12191
  Complete submission text file 0001209191-21-034631.txt   13622
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3135 HUTTON DRIVE BEVERLY HILLS CA 90210
Business Address
Jakobovits Aya (Reporting) CIK: 0001823901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 21946149